Loading clinical trials...

Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW) | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)

NCT06177574•Carmen Hidalgo Tenorio

View on ClinicalTrials.gov

Summary

The goal of this study is to analyze in treatment-naïve HIV patients the antiviral activity, using a test and treat strategy, in real life of BIC/FTC/TAF. Secondary, this study aims to evaluate outcomes for implementation of the evidence based test and treat strategy.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. HIV-1 infected adults (\>17 y.o.)
•2. Antiretroviral-naïve.
•3. Be able to comply with protocol requirements and instructions.
•4. Subject or the subject's representative capable of giving signed informed consent

Exclusion Criteria

•1. Women who are breastfeeding or plan to become pregnant during the study.
•2. Patients who in the investigator's judgment, poses a significant drop out risk or life expectancy inferior to study ending.
•3. Patients with anticipated need to change the ART before study ending.

Locations (15)

Hospital Universitario Virgen de Las Nieves

Granada, Andalusia, Spain

H JEREZ

Jerez de la Frontera, Cádiz, Spain

Hospital Universitario Torrecárdenas

Almería, Spain

Hospital Universitario Puerto Real, INIBICA,

Cadiz, Spain

Hospital Campus de la Salud

Granada, Spain

Complejo Hospitalario de Jaén,

Jaén, Spain

Hospital Clínico San Carlos, Complutense University, CIBERINFEC ISCIII, Madrid, Spain

Madrid, Spain

Hu Infanta Leonor

Madrid, Spain

Hu La Princesa

Madrid, Spain

Ramon Y Cajal

Madrid, Spain

Key Dates

Start Date

October 27, 2020

Primary Completion Date

October 30, 2023

Completion Date

October 30, 2023

Last Updated

December 20, 2023

Enrollment

208

ACTUAL participants

Conditions

HIV Infections

Interventions

BIC/FTC/TAF

DRUG

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

HIVHIV Infections

View study

RECRUITINGPHASE3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

HIV Infections

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)

Inclusion Criteria

Exclusion Criteria

Skeletal Muscle Energetics and Fatiguability in Older Individuals

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

Comprehensive HIV and Harm Prevention Via Telehealth